These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29534537)

  • 1. Discovery of Oxime Ethers as Hepatitis B Virus (HBV) Inhibitors by Docking, Screening and In Vitro Investigation.
    Tan J; Zhou M; Cui X; Wei Z; Wei W
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29534537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Design, virtual screening, synthesis and anti-hepatitis B virus of oxime derivatives].
    Cui XH; Tan J; Zhou M; Wei WX; Liu X; Wang LS
    Yao Xue Xue Bao; 2016 Oct; 51(10):1578-83. PubMed ID: 29932603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
    Liu S; Wei W; Li Y; Liu X; Cao X; Lei K; Zhou M
    Eur J Med Chem; 2015 May; 95():473-82. PubMed ID: 25847765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis and Bioactive Evaluation of Oxime Derivatives of Dehydrocholic Acid as Anti-Hepatitis B Virus Agents.
    Wei Z; Tan J; Cui X; Zhou M; Huang Y; Zang N; Chen Z; Wei W
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32722086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis, and Bioactive Screen In Vitro of Cyclohexyl (
    Cui X; Zhou M; Tan J; Wei Z; Wei W; Luo P; Lin C
    Molecules; 2019 May; 24(11):. PubMed ID: 31151219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives.
    Liu S; Li Y; Wei W; Wang K; Wang L; Wang J
    Chem Biol Interact; 2016 May; 251():1-9. PubMed ID: 26980103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents.
    Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Guo RH; Zhang XM; Chen JJ
    Bioorg Med Chem; 2012 May; 20(9):2877-88. PubMed ID: 22472044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents.
    Guo RH; Zhang Q; Ma YB; Luo J; Geng CA; Wang LJ; Zhang XM; Zhou J; Jiang ZY; Chen JJ
    Eur J Med Chem; 2011 Jan; 46(1):307-19. PubMed ID: 21145140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of celastrol derivatives as potential non-nucleoside hepatitis B virus inhibitors.
    Zhang H; Lu G
    Chem Biol Drug Des; 2020 Dec; 96(6):1380-1386. PubMed ID: 32573976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors.
    Jia H; Bai F; Liu N; Liang X; Zhan P; Ma C; Jiang X; Liu X
    Eur J Med Chem; 2016 Nov; 123():202-210. PubMed ID: 27484509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-hepatitis B virus activities of friedelolactones from Viola diffusa Ging.
    Dai JJ; Tao HM; Min QX; Zhu QH
    Phytomedicine; 2015 Jul; 22(7-8):724-9. PubMed ID: 26141758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of hepatitis B virus subviral particle biogenesis inhibitors from a bioactive compound library.
    Shrestha B; Yang S; Griffith L; Ma J; Wang F; Liu H; Zhao Q; Du Y; Zhang J; Chang J; Guo JT
    Antiviral Res; 2024 Aug; 228():105955. PubMed ID: 38964614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of caudatin analogs as potent hepatitis B virus inhibitors.
    Wang LJ; Chen H; Ma YB; Huang XY; Geng CA; Zhang XM; Chen JJ
    Med Chem; 2015; 11(2):165-79. PubMed ID: 25181984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HBV agents. Part 2: synthesis and in vitro anti-hepatitis B virus activities of alisol A derivatives.
    Zhang Q; Jiang ZY; Luo J; Liu JF; Ma YB; Guo RH; Zhang XM; Zhou J; Chen JJ
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2148-53. PubMed ID: 19289281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-hepatitis B virus active constituents from Swertia chirayita.
    Zhou NJ; Geng CA; Huang XY; Ma YB; Zhang XM; Wang JL; Chen JJ
    Fitoterapia; 2015 Jan; 100():27-34. PubMed ID: 25447162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hepatitis B virus activity of wogonin in vitro and in vivo.
    Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J
    Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo anti-hepatitis B virus activities of the lignan niranthin isolated from Phyllanthus niruri L.
    Liu S; Wei W; Shi K; Cao X; Zhou M; Liu Z
    J Ethnopharmacol; 2014 Sep; 155(2):1061-7. PubMed ID: 25009077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro.
    Boulon R; Blanchet M; Lemasson M; Vaillant A; Labonté P
    Antiviral Res; 2020 Nov; 183():104853. PubMed ID: 32585322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus.
    Pang YJ; Tan XJ; Li DM; Zheng ZH; Lei RX; Peng XM
    Liver Int; 2013 Sep; 33(8):1230-8. PubMed ID: 23617302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
    Huang TJ; Yang CL; Kuo YC; Chang YC; Yang LM; Chou BH; Lin SJ
    Bioorg Med Chem; 2015 Feb; 23(4):720-8. PubMed ID: 25600408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.